Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2023-04-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 21st meeting of the 5th Board of Directors of 阳普医疗科技股份有限公司. It includes approvals of various reports such as the 2022 Annual Report, 2022 Annual Financial Statements, 2023 Q1 Report, internal control self-evaluation, profit distribution plan, and other corporate governance matters. The document repeatedly states that these reports and detailed documents are available on the designated disclosure website and that these resolutions will be submitted to the shareholders' meeting for approval. The document itself does not contain the full financial statements or detailed report content but rather summarizes the board's decisions and approvals. It is a formal board meeting resolution announcement, which fits best under the category of Board/Management Information (MANG), as it announces board meeting decisions and management reports approval. It is not the full Annual Report (10-K), nor is it a simple announcement of report publication (RPA), since it contains substantive board resolutions. Therefore, the classification is MANG with high confidence.
2023-04-26 Chinese
关于全资子公司收到医疗器械注册变更文件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (750 characters) from a company about its wholly-owned subsidiary receiving a medical device registration change document from a regulatory authority (Guangdong Provincial Drug Administration). It details the change in product registration information and its impact on the company. There is no financial data, no mention of financial results, no detailed report, and no indication that this is a report or presentation. It is an official regulatory announcement about a product registration change, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like financial reports, management changes, or capital updates.
2023-04-24 Chinese
关于全资子公司收到医疗器械变更注册（备案）文件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (710 characters) from a company about its wholly owned subsidiary receiving a medical device change registration (filing) from a regulatory authority (National Medical Products Administration). It describes the change in production address for a medical device and its potential impact. There is no financial data, no detailed report, no earnings or management discussion, and no mention of shareholder votes or capital changes. The document is an official regulatory announcement about a product registration change, not a financial report or meeting material. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-03-08 Chinese
关于全资子公司完成法定代表人变更并换领相关证照的公告
Board/Management Information Classification · 95% confidence The document is an official announcement from Yangpu Medical Technology Co., Ltd. regarding the change of the legal representative of its wholly-owned subsidiary, Guangzhou Yangpu Medical Device Co., Ltd. It details the updated business licenses and permits with new legal representative information. The document does not contain financial data, management discussion, or report content. It is a regulatory announcement about management changes at the subsidiary level, specifically the legal representative change and related license updates. This fits best under Board/Management Information (MANG) as it concerns changes in company management representation.
2023-02-22 Chinese
关于控股子公司股权转让进展暨完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the progress and completion of a subsidiary's equity transfer and related industrial and commercial registration changes. It details the transfer of 83.33% equity of a subsidiary to another company, payment receipt, and completion of registration. There is no financial data, no detailed report, no meeting materials, or voting results. It is a regulatory announcement about a corporate transaction but not a merger filing or capital change announcement. It fits best under Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2023-02-07 Chinese
2022年年度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a '2022 Annual Performance Forecast' (业绩预告) and provides estimated financial results for the full year 2022, including expected net profit/loss figures and explanations for performance changes. It explicitly states that the data is preliminary, unaudited, and subject to the final 2022 Annual Report. The document is short (1281 characters) and serves as a performance forecast announcement rather than a full financial report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial statements and detailed analysis. Therefore, the correct classification is Earnings Release (ER). FY 2022
2023-01-19 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.